Migraines In Women: How Hormones Influence Neurological Health
For those who have not experienced a migraine, perhaps it would seem just another headache. But for someone like me who has suffered through migraines that will last over a week even with medication, I can definitely tell you that it's much more. The ache is not confined to the head; it's the whole experience. Nausea, sensitivity to light, and throbs so bad it makes simple tasks unbearable. It also comes with an emotional burden—the loneliness and frustration are pretty unbearable. Through the years, realizing how hormones are also implicated in triggering and exacerbating my migraines has helped change the game in my dealing with these episodes.
Hormonal migraines are caused by fluctuations in estrogen and progesterone, the two main female hormones. These hormones are essential for the reproductive system, regulating menstrual cycles and pregnancy. They also have an effect on brain chemicals, such as serotonin and dopamine, which affect mood and pain perception. When hormone levels fluctuate, such as during menstruation, pregnancy, or menopause, they can destabilize the pathways in the brain, causing migraines.
According to Dr. Shivananda Pai, Consultant Neurology, migraines are more than a neurological disorder. "Migraines represent a complex interplay of genetic, environmental, and hormonal factors. In women, hormonal fluctuations are a critical trigger that amplifies sensitivity to pain," he explains. Hormonal headaches are particularly challenging because they are influenced by multiple life stages, from puberty to post-menopause. Common causes include:
Estrogen, often called the "hormone of femininity", does more than regulate reproductive functions. It is a powerful influencer of brain health. Estrogen modulates the activity of neurotransmitters like serotonin, which regulates mood and pain perception, and dopamine, associated with reward and pleasure.
During stages of hormonal stability, like in pregnancy's latter months, women may have fewer migraines because of the steady elevation of estrogen. However, a sudden downfall in estrogen destabilizes these chemicals in the brain, sending a heightened sensitivity for migraine triggers.
The most common form of hormonal migraines is menstrual migraines, which occur in response to the steep decline in estrogen levels just before menstruation. These are typically more intense and less responsive to standard treatment. The timing of these migraines provides clear evidence of the role hormones play in neurological health.
Pregnancy is a rollercoaster of hormones. Although many women experience relief from migraines as a result of the constantly elevated levels of estrogen, some women, particularly in the first trimester, worsen. This individual variability is a characteristic of hormonal migraine triggers.
Hormonal treatments, such as oral contraceptives and HRT, have had mixed reviews regarding their use in managing migraine. Some women fare better with the stabilization the treatment provides, whereas others suffer worsening symptoms. This will depend on the nature and dose of the hormones used.
For most women, menopause brings relief from their migraines. The decline in frequency and severity often accompanies stability in hormone levels. Even so, the susceptibility remains with some towards other forms of triggers including stress and sleep deprivation, not to forget diet-related factors and continues the saga of migraines well after the menopausal stages.
The relationship of hormones to neurological health goes beyond migraines. Hormonal changes have profound effects on a woman's brain in general.
Mood Disorders: Estrogen helps stabilize mood by regulating serotonin. Its decline at menopause increases the risk of mood swings and depression.
Neurodegenerative Diseases: Estrogen is neuroprotective, stimulating the growth and repair of brain cells. Its absence in post-menopausal women has been associated with an increased risk of Alzheimer's disease and cognitive decline.
Multiple Sclerosis (MS): Hormonal cycles may affect the course of MS, a disease that occurs more frequently in women than in men. Estrogen's anti-inflammatory effects provide transient protection during pregnancy, reducing relapse rates in women with MS.
"The intricate interplay between hormones and neurological health underscores the need for gender-specific treatment approaches," says Dr. Pai.
While hormonal changes are inevitable, several strategies can help manage migraines effectively:
Understanding your menstrual cycle can help identify patterns and predict when migraines might occur. This knowledge allows for preventive measures, such as scheduling medications or adjusting lifestyle habits.
Working with a neurologist or gynecologist can help develop a personalized treatment plan. Options might include hormonal therapies, triptans, or preventive medications tailored to your specific needs.
A well-balanced diet, regular exercise, and stress management are all integral parts of managing migraines. For instance, magnesium-rich foods and hydration can help reduce the frequency and severity of attacks.
For people with severe or frequent migraines, preventive medications, such as beta-blockers or CGRP inhibitors, may be prescribed. These medications stabilize brain activity and therefore reduce the chances of migraine during hormonal fluctuations.
Techniques like yoga, meditation, and biofeedback can enhance wellness and reduce the debilitating effects of stress-one of the most common migraine triggers.
Research that was once in its embryonic stage continues to shed more light on the role of hormones in migraines and other neurological conditions. Further breakthroughs in genetic testing might enable doctors to predict, at least in a way, how an individual would react to hormonal therapies. The importance of gender-specific approaches is gradually being realized, which involves differentiating between the plight of women with migraines from others.
As Dr. Pai puts it, "Empowering women with knowledge about the hormonal underpinnings of migraines can lead to better, more personalized care. With the right strategies, migraines can be effectively managed, allowing women to lead fuller, healthier lives.
Migraines are not headaches; they are a complex neurological condition that deeply impacts the lives of millions of women. Understanding the role of hormones in triggering and exacerbating migraines is a vital step toward better management and relief.
Awareness, proactive care, and advances in medical research can help women regain their lives from the grip of hormonal migraines. Whether tracking cycles, adopting healthier habits, or seeking tailored medical care, every step taken toward understanding and managing migraines is a step toward empowerment.
Dr Shivananda Pai is a Consultant Neurology at KMC Hospital Dr B R Ambedkar Circle in Mangalore, India.
Brandes JL. The Influence of Estrogen on Migraine: A Systematic Review. JAMA. 2006;295(15):1824–1830. doi:10.1001/jama.295.15.1824
Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012 Apr;13(3):177-89. doi: 10.1007/s10194-012-0424-y. Epub 2012 Feb 26. PMID: 22367631; PMCID: PMC3311830.
Credits: Canva
Deceased organ donation covers our organ needs. In India, we are woefully short of organs such as kidneys and livers in cases of liver and kidney failure that need to be transplanted.
Deceased donation, as the name sounds, is a donation by people who are brain dead, whose family has now accepted and has willingly donated their organs for the benefit of the rest of the world.
Live donation, on the other hand, is a donation by living or emotionally related individuals who want to donate a kidney to a diseased patient. A live donation is usually transplanted immediately. It's done in the same centre, and both are done together, as the harvesting of the organ from the donor and transplantation are done simultaneously.
On the other hand, a deceased organ from a cadaveric donor may be harvested in a different geographical location and may be transported over time and over a lot of distance to another centre.
Deceased donation can be done for organs that cannot be transplanted by live donation, which are so consequential to a human body, such as the heart, lungs, and pancreas. They are very vital and cannot be transplanted from a live patient to another.
In a deceased organ donation, we can even donate tissues such as the cornea, skin, and blood vessels, which are required as a part of donation, as a part of other organ donation transplant programmes or, for example, in giving vision to people who have a white cornea or corneal opacity.
These are a few differences between live and deceased or cadaveric donation.
Dr. Vikram Shah Batra, Director - Urology, Kidney Transplant and Uro Oncology, Max Super Speciality Hospital, Dwarka
Credits: Canva
A uterine growth diagnosis can be very alarming. That said, it is vital to note that such growths are often simple, run-of-the-mill fibroids. They are non-cancerous, very common, and completely harmless. At the same time, it is important to realise what uterine sarcoma is, and why fibroids are often confused with uterine sarcoma. It comes down to anatomy. The uterus consists mainly of smooth muscle tissue. A fibroid is just an overgrowth of this smooth muscle that expands over time. Uterine sarcoma is a rare cancer that originates within that very same muscle wall. Since both develop in the same spot, they tend to trigger identical symptoms—like unexpected bleeding, pelvic aching, or pressure.
Before starting treatment, it is important to fully understand what the diagnosis is, as that is the first step to safety.
Surgeons often treat routine fibroids with minimally invasive techniques. These methods break or chop the tissue into smaller fragments so it can be pulled through tiny incisions. If a growth, however, turns out to be an unsuspected sarcoma, breaking it apart inside the pelvis can spread malignant cells. A thorough diagnostic workup beforehand makes sure nothing gets disrupted accidentally, so that the surgical team builds the safest possible treatment plan.
Here is some genuine peace of mind: benign fibroids don't suddenly turn into cancer. Medical research shows that malignant transformation inside an existing fibroid is exceptionally rare. Because fibroids and sarcomas are biologically different conditions from the start, monitoring a standard fibroid does not put you at risk of it turning into a tumor down the line.
Most fibroids stay completely harmless throughout life. It is, however, important to watch out for a few specific red flags:
Post-menopause changes: Fibroids shrink on their own once hormone levels drop after menopause. Any new growth or spotting at this stage demands a closer look.
Growths that keep expanding on medication: If a mass gets bigger while one is on prescriptions designed to shrink it, the patient must seek out a secondary review.
Ambiguous scans: When a routine ultrasound shows atypical tissue structure, stepping up to advanced imaging helps clear up the picture.
Following an ultrasound, it is recommended to opt for a dedicated pelvic MRI for a much sharper view of the uterine muscle wall to confirm whether a mass is truly benign.
Getting a second opinion from a specialist is a normal, proactive move. It is especially critical if:
The good news is that uterine sarcomas are remarkably rare, making up just 2% to 5% of all uterine cancers. A patient needs to be cognizant by paying attention to changes in the body and asking questions about the scans.
Dr Bindhu KS - Sr. Consultant Obstetrics, Gynaecology & Robotic Surgery, Apollo Hospitals Navi Mumbai
Credit: AI
For many women, polycystic ovary syndrome (PCOS) begins with a familiar story—irregular periods, acne, unwanted hair growth or difficulty conceiving. But PCOS is far more than a reproductive disorder. At its core, it is often a complex interplay between metabolism, hormones and reproductive health.
One of the most important, yet frequently overlooked, pieces of this puzzle is insulin resistance. When the body becomes less responsive to insulin, the pancreas compensates by producing more.
Elevated insulin levels can, in turn, contribute to increased androgen production by the ovaries and disrupt the delicate hormonal signals required for regular ovulation. The result may be irregular cycles, fewer ovulations and, for some women, difficulty becoming pregnant.
PCOS And Insulin Resistance Can Affect Women Of Any Weight
Importantly, PCOS and insulin resistance are not synonymous with obesity. Women with a healthy body weight can also have significant metabolic abnormalities. This is why judging metabolic health by appearance alone can be misleading.
The 2023 International Evidence-based PCOS Guideline recognises insulin resistance as an important underlying feature and recommends attention to metabolic risk across the weight spectrum.
Also read: Decoding The Fertility Markers
The Metabolic Risks Go Beyond Fertility
The metabolic implications extend well beyond fertility. Women with PCOS have a higher risk of impaired glucose tolerance and type 2 diabetes, making long-term metabolic surveillance an important part of care.
The guideline recommends appropriate glycaemic assessment, particularly when pregnancy is being planned or fertility treatment is being considered.
Also read: Can Regular Consumption of Junk and Processed Food Affect Fertility?
Building A Healthier Foundation For Pregnancy
Yet there is an equally important message of hope: PCOS does not mean infertility, nor does it have to define a woman’s health journey. Lifestyle interventions—including regular physical activity, nutritious eating, adequate sleep and sustainable weight management where appropriate—form the foundation of care and can improve metabolic health.
For a woman planning pregnancy, the goal should not simply be to “get pregnant.” It should be to enter pregnancy metabolically and emotionally healthier, with blood sugar, blood pressure, nutrition, lifestyle and other risk factors appropriately addressed.
Take-home message: PCOS is not merely about irregular periods or cysts on the ovaries. It is a lifelong condition in which metabolic health and reproductive health are deeply connected. Recognising insulin resistance early, looking beyond weight, and providing personalised care can help women protect both their fertility today and their health for years to come.
© $2026 Times Horizon Private Limited